Navid Redjal1, Andrew S Venteicher2, Danielle Dang3, Andrew Sloan4, Remi A Kessler5, Rebecca R Baron5, Constantinos G Hadjipanayis5, Clark C Chen2, Mateo Ziu3, Jeffrey J Olson6, Brian V Nahed7. 1. Department of Neurosurgery, Capital Institute for Neurosciences, Two Capital Way, Pennington, NJ, 08534, USA. nredjal@capitalhealth.org. 2. Center for Pituitary and Skull Base Surgery, Department of Neurosurgery, University of Minnesota, Minneapolis, MN, 55455, USA. 3. Inova Neuroscience and Spine Institute, 3300 Gallows Rd, Falls Church, VA, 22042, USA. 4. Department of Neurosurgery, Case Western Reserve University, Cleveland, OH, USA. 5. Department of Neurosurgery, Icahn School of Medicine at Mount Sinai, New York, NY, USA. 6. Department of Neurosurgery, Emory University, Atlanta, GA, USA. 7. Department of Neurosurgery, Massachusetts General Hospital, Boston, MA, USA.
Abstract
INTRODUCTION: Evidence-based, clinical practice guidelines in the management of central nervous system tumors (CNS) continue to be developed and updated through the work of the Joint Section on Tumors of the Congress of Neurological Surgeons (CNS) and the American Association of Neurological Surgeons (AANS). METHODS: The guidelines are created using the most current and clinically relevant evidence using systematic methodologies, which classify available data and provide recommendations for clinical practice. CONCLUSION: This update summarizes the Tumor Section Guidelines developed over the last five years for non-functioning pituitary adenomas, low grade gliomas, vestibular schwannomas, and metastatic brain tumors.
INTRODUCTION: Evidence-based, clinical practice guidelines in the management of central nervous system tumors (CNS) continue to be developed and updated through the work of the Joint Section on Tumors of the Congress of Neurological Surgeons (CNS) and the American Association of Neurological Surgeons (AANS). METHODS: The guidelines are created using the most current and clinically relevant evidence using systematic methodologies, which classify available data and provide recommendations for clinical practice. CONCLUSION: This update summarizes the Tumor Section Guidelines developed over the last five years for non-functioning pituitary adenomas, low grade gliomas, vestibular schwannomas, and metastatic brain tumors.
Authors: Julian H Barth; Shivani Misra; Kristin Moberg Aakre; Michel R Langlois; Joseph Watine; Patrick J Twomey; Wytze P Oosterhuis Journal: Clin Chem Lab Med Date: 2016-07-01 Impact factor: 3.694
Authors: Meike W Vernooij; M Arfan Ikram; Hervé L Tanghe; Arnaud J P E Vincent; Albert Hofman; Gabriel P Krestin; Wiro J Niessen; Monique M B Breteler; Aad van der Lugt Journal: N Engl J Med Date: 2007-11-01 Impact factor: 91.245